MIBG (123I) 74 MBq/mL solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

mibg (123i) 74 mbq/ml solution for injection

curium netherlands b.v. - iobenguane - solution for injection - 74 megabecquerel(s)/millilitre - other diagnostic radiopharmaceuticals for tumour detection; iobenguane (123i)

[¹³¹I] Meta-Iodobenzylguanidine for Diagnostic Use Malta - English - Medicines Authority

[¹³¹i] meta-iodobenzylguanidine for diagnostic use

ge healthcare limited - iobenguane - solution for injection - iobenguane - diagnostic radiopharmaceuticals

[¹³¹I] Meta-Iodobenzylguanidine for Diagnostic Use solution for intravenous injection Malta - English - Medicines Authority

[¹³¹i] meta-iodobenzylguanidine for diagnostic use solution for intravenous injection

ge healthcare buchler gmbh & co. gieselweg 1, 38110 braunschweig, germany - iobenguane - solution for injection - iobenguane - diagnostic radiopharmaceuticals

Locametz European Union - English - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - radionuclide imaging - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.4).

DOPACIS 90 MBq/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

dopacis 90 mbq/ml solution for injection

cis bio international - fluorodopa (18 f) - solution for injection - 90 mbq/ml - other diagnostic radiopharmaceuticals for tumour detection

Dopacis 90 MBq/mL solution for injection Malta - English - Medicines Authority

dopacis 90 mbq/ml solution for injection

cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - fluorodopa - solution for injection - fluorodopa (18f) 90 mbq/ml - diagnostic radiopharmaceuticals

IASOcholine 1 GBq/mL, solution for injection Malta - English - Medicines Authority

iasocholine 1 gbq/ml, solution for injection

iason gmbh feldkirchner str. 4, a-8054 graz, austria - fluorocholine - solution for injection - fluorocholine (18-f) 100 mbq/ml - diagnostic radiopharmaceuticals

ERtracER Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

ertracer solution for injection

curium pharma ireland limited - fludeoxyglucose [18f] - solution for injection - 110-10,000 megabecquerel(s)/millilitre - other diagnostic radiopharmaceuticals for tumour detection; fludeoxyglucose (18f)

Lymphoseek European Union - English - EMA (European Medicines Agency)

lymphoseek

navidea biopharmaceuticals europe ltd. - tilmanocept - radionuclide imaging - tumour detection, diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.radiolabelled lymphoseek is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity.external imaging and intraoperative evaluation may be performed using a gamma detection device.

SomaKit TOC European Union - English - EMA (European Medicines Agency)

somakit toc

advanced accelerator applications - edotreotide - neuroendocrine tumors; radionuclide imaging - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.after radiolabelling with gallium (68ga) chloride solution, the solution of gallium (68ga) edotreotide obtained is indicated for positron emission tomography (pet) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastro-enteropancreatic neuroendocrine tumours (gep-net) for localizing primary tumours and their metastases.